{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:54:36Z","timestamp":1777294476531,"version":"3.51.4"},"posted":{"date-parts":[[2026,4,23]]},"group-title":"HIV\/AIDS","reference-count":53,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Understanding provider preferences for the design of HIV treatment packages could enhance the implementation of programs to support the adoption of long-acting injectable antiretroviral therapy (LAI ART) by people living with HIV who are interested in initiating this treatment modality.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We recruited providers from New York City (NYC), Rockland, Putman, and Westchester County Ryan White Part A Medical Case Management (MCM) programs to complete a discrete choice experiment (DCE) containing twelve tasks with two alternatives and an opt-out option, with additional survey questions about implementation readiness and choice motivations. The alternatives included four attributes\u2014Type of ART Medication (monthly or bimonthly LAI ART), Service Location and Mode, Support for Clients, and Rewards for Clients\u2014 with 2\u20134 levels each. We ran latent class multinomial logit analyses (LCA) with 1\u20135 classes to estimate preferences and explore hypothesis-free preference heterogeneity. We estimated attribute influence using relative importances and preferences using zero-centered part-worth utilities for each level.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>One hundred seventy-seven providers completed the survey (July 2022\u2013January 2023). About half (52%) were 40\u201359 years old, 72% identified as women, and the plurality (41%) identified as Latino\/a. We chose the two-group LCA solution. Bimonthly LAI ART was preferred over monthly LAI ART overall and in both groups. Group 1 (n=45) preferred more traditional adherence supports (e.g., injections at the clinic by appointment, injection appointment reminders) whereas Group 2 (n=132) preferred more client-centered supports (e.g., injections at home by appointment, free transportation to injection appointments if at a clinic). Both groups preferred higher monetary value gift cards for clients for every on-time injection. The top-ranking motivations indicated that participants prioritized patient convenience over job satisfaction and administrative or financial feasibility for the agency. The scores for all implementation measures indicate readiness to implement LAI ART in both groups.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our implementation science-focused study suggests that providers of MCM services in NYC and surrounding counties are motivated to offer services to support clients\u2019 access and adherence to LAI ART. More work is needed to understand how programs have, in fact, integrated supports for LAI ART into their services.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.04.22.26351494","type":"posted-content","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:45:13Z","timestamp":1776984313000},"source":"Crossref","is-referenced-by-count":0,"title":["Exploring provider preferences in the design of HIV treatment packages integrating long-acting injectable antiretroviral therapy in New York Ryan White Part A medical case management programs: A discrete choice experiment"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5278-3930","authenticated-orcid":false,"given":"Rebecca","family":"Zimba","sequence":"first","affiliation":[{"name":"CUNY Institute for Implementation Science in Population Health, City University of New York, New York, NY, USA"},{"name":"Department of Epidemiology and Biostatistics, CUNY Graduate School of Public Health and Health Policy, City University of New York, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0566-8697","authenticated-orcid":false,"given":"Elizabeth A.","family":"Kelvin","sequence":"additional","affiliation":[{"name":"CUNY Institute for Implementation Science in Population Health, City University of New York, New York, NY, USA"},{"name":"Department of Epidemiology and Biostatistics, CUNY Graduate School of Public Health and Health Policy, City University of New York, New York, NY, USA"},{"name":"Donald and Barbara Zucker School of Medicine at Hofstra University\/Northwell Health, Hempstead, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0807-339X","authenticated-orcid":false,"given":"Sarah","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"CUNY Institute for Implementation Science in Population Health, City University of New York, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7240-9625","authenticated-orcid":false,"given":"Jennifer","family":"Carmona","sequence":"additional","affiliation":[{"name":"Division of Disease Control, New York City Department of Health and Mental Hygiene, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6202-2043","authenticated-orcid":false,"given":"Tigran","family":"Avoundjian","sequence":"additional","affiliation":[{"name":"CUNY Institute for Implementation Science in Population Health, City University of New York, New York, NY, USA"},{"name":"Bureau of HIV, Hepatitis, and Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9691-1146","authenticated-orcid":false,"given":"Connor","family":"Emmert","sequence":"additional","affiliation":[{"name":"Bureau of HIV, Hepatitis, and Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Peterson","sequence":"additional","affiliation":[{"name":"Bureau of HIV, Hepatitis, and Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-7559","authenticated-orcid":false,"given":"Mary","family":"Irvine","sequence":"additional","affiliation":[{"name":"Bureau of HIV, Hepatitis, and Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3280-5386","authenticated-orcid":false,"given":"Denis","family":"Nash","sequence":"additional","affiliation":[{"name":"CUNY Institute for Implementation Science in Population Health, City University of New York, New York, NY, USA"},{"name":"Department of Epidemiology and Biostatistics, CUNY Graduate School of Public Health and Health Policy, City University of New York, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026042704500632000_2026.04.22.26351494v1.1","unstructured":"HIV\/AIDS Bureau, Division of Metropolitan HIV\/AIDS Programs National Monitoring Standards for Ryan White Part A Grantees: Program \u2013 Part A 21\u201323 (2013)."},{"key":"2026042704500632000_2026.04.22.26351494v1.2","unstructured":"Health Resources & Services Administration. Overview of Clients: HRSA\u2019s Ryan White HIV\/AIDS Program, 2022. 2024. April, 2024. https:\/\/targethiv.org\/sites\/default\/files\/media\/documents\/2024-10\/Overview-of-Clients-HRSA-RWHAP-2022.pdf"},{"key":"2026042704500632000_2026.04.22.26351494v1.3","unstructured":"Centers for Disease Control and Prevention. HIV Care Coordination Program: Evidence-Informed for Retention in HIV Care. Accessed 22 November, 2015. http:\/\/www.cdc.gov\/hiv\/pdf\/prevention\/research\/compendium\/cdc-hiv-HIVCCP_EI_Retention.pdf"},{"key":"2026042704500632000_2026.04.22.26351494v1.4","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell L , Irvine MK , Wilkes AL , et al. STEPS to Care: Translating an Evidence-informed HIV Care Coordination Program into a Field-Tested Online Practice Improvement Toolkit. AIDS Education and Prevention: An Interdisciplinary Journal. In press;32(4)","DOI":"10.1521\/aeap.2020.32.4.296"},{"key":"2026042704500632000_2026.04.22.26351494v1.5","unstructured":"Hygiene NYCDoHaM. HIV Care Coordination. New York City Department of Health and Mental Hygiene. Accessed August 18, 2017. https:\/\/www1.nyc.gov\/site\/doh\/health\/health-topics\/aids-hiv-care-coord.page"},{"key":"2026042704500632000_2026.04.22.26351494v1.6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu783"},{"key":"2026042704500632000_2026.04.22.26351494v1.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-016-1460-4"},{"key":"2026042704500632000_2026.04.22.26351494v1.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204017"},{"key":"2026042704500632000_2026.04.22.26351494v1.9","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001877"},{"key":"2026042704500632000_2026.04.22.26351494v1.10","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-019-02732-0"},{"key":"2026042704500632000_2026.04.22.26351494v1.11","unstructured":"HIV Care and Treatment Program, Bureau of Hepatitis, HIV, and Sexually Transmitted Infections. Unpublished data. New York City Department of Health and Mental Hygiene; 2025."},{"key":"2026042704500632000_2026.04.22.26351494v1.12","unstructured":"Thomas JA , Irvine MK , Penrose K , Casey A , Harriman G , Braunstein SL . Assembling a fuller picture of Ryan White Part A clients using data from program reporting, surveillance, claims, and surveys presented at: Ryan White Conference on HIV Care and Treatment; December 9\u201314 2018; Oxon Hill, MD. https:\/\/www1.nyc.gov\/assets\/doh\/downloads\/pdf\/dires\/2018-assembling-fuller-picture-of-ryan-white-part-a-data.pdf"},{"key":"2026042704500632000_2026.04.22.26351494v1.13","unstructured":"Health NYSDo. Uninsured Care Programs - Summary. Accessed 24 August, 2020. https:\/\/www.health.ny.gov\/diseases\/aids\/general\/resources\/adap\/index.htm"},{"key":"2026042704500632000_2026.04.22.26351494v1.14","doi-asserted-by":"crossref","unstructured":"Xia Q , Lazar R , Bernard MA , et al. New York City Achieves the UNAIDS 90-90-90 Targets for HIV-infected Whites but not Latinos\/Hispanics and Blacks. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2016;","DOI":"10.1097\/QAI.0000000000001132"},{"key":"2026042704500632000_2026.04.22.26351494v1.15","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz022"},{"key":"2026042704500632000_2026.04.22.26351494v1.16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit595"},{"key":"2026042704500632000_2026.04.22.26351494v1.17","unstructured":"FDA. FDA approves first extended-release, injectable drug regimen for adults living with HIV. US Food and Drug Adminsitration (FDA). Accessed DEcember 27, 2023, 2023. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-extended-release-injectable-drug-regimen-adults-living-hiv"},{"key":"2026042704500632000_2026.04.22.26351494v1.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904398"},{"key":"2026042704500632000_2026.04.22.26351494v1.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1909512"},{"key":"2026042704500632000_2026.04.22.26351494v1.20","unstructured":"Orkin C , Oka S , Philibert P , et al. Long-acting Cabotegravir + Rilpivirine for HIV treatment: FLAIR week 96 results. presented at: Conference on Retroviruses and Opportunistic Infections; 8-11 March 2020 2020; Boston, MA Session 482. Accessed 27 July 2020. https:\/\/d201nm4szfwn7c.cloudfront.net\/5f95dbd7-245e-4e65-9f36-1a99e28e5bba\/95ff2149-c458-43e3-bcee-363c1caf9a2f\/95ff2149-c458-43e3-bcee-363c1caf9a2f_viewable_renditionv.pdf"},{"key":"2026042704500632000_2026.04.22.26351494v1.21","unstructured":"Overton ET , Richmond G , Rizzardini G , et al. Cabotegravir + Rilpivirine every 2 months is noninferior to monthly dosing: Week 48 results from the ATLAS-2M study. presented at: Conference on Retroviruses and Opportunistic Infections; 8-11 March 2020 2020; Boston, MA Session 3334. Accessed 27 July 2020. https:\/\/d201nm4szfwn7c.cloudfront.net\/5f95dbd7-245e-4e65-9f36-1a99e28e5bba\/3145ba37-7c49-46a1-8bff-68fcf5ed2a59\/3145ba37-7c49-46a1-8bff-68fcf5ed2a59_viewable_renditionv.pdf"},{"key":"2026042704500632000_2026.04.22.26351494v1.22","unstructured":"Dear Ryan White HIV\/ AIDS Program Part B AIDS Drug Assistance Program Colleagues (2019)."},{"key":"2026042704500632000_2026.04.22.26351494v1.23","unstructured":"US Department of Health and Human Services. Ending the HIV Epidemic: Key EHE Strategies. Updated 7\/15\/24. Accessed 6\/16\/25, 2025. https:\/\/www.hiv.gov\/federal-response\/ending-the-hiv-epidemic\/key-strategies"},{"key":"2026042704500632000_2026.04.22.26351494v1.24","unstructured":"UNAIDS. 2025 AIDS Targets. Accessed 6\/16\/2025, 2025. https:\/\/aidstargets2025.unaids.org\/"},{"key":"2026042704500632000_2026.04.22.26351494v1.25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272405"},{"key":"2026042704500632000_2026.04.22.26351494v1.26","doi-asserted-by":"publisher","DOI":"10.1097\/coh.0000000000000166"},{"key":"2026042704500632000_2026.04.22.26351494v1.27","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy247"},{"key":"2026042704500632000_2026.04.22.26351494v1.28","doi-asserted-by":"publisher","DOI":"10.64898\/2026.02.13.26346257"},{"key":"2026042704500632000_2026.04.22.26351494v1.29","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000158"},{"key":"2026042704500632000_2026.04.22.26351494v1.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2002199"},{"issue":"7","key":"2026042704500632000_2026.04.22.26351494v1.31","doi-asserted-by":"crossref","first-page":"ofad341","DOI":"10.1093\/ofid\/ofad341","article-title":"Acceptability, Feasibility, and Appropriateness of Implementation of Long-acting Injectable Antiretrovirals: A National Survey of Ryan White Clinics in the United States","volume":"10","year":"2023","journal-title":"Open Forum Infectious Diseases"},{"issue":"128","key":"2026042704500632000_2026.04.22.26351494v1.32","first-page":"1","article-title":"Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives","volume":"4","year":"2023","journal-title":"Implementation Science Communication"},{"issue":"1","key":"2026042704500632000_2026.04.22.26351494v1.33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12913-021-06214-9","article-title":"Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials","volume":"21","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"2026042704500632000_2026.04.22.26351494v1.34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262926"},{"key":"2026042704500632000_2026.04.22.26351494v1.35","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26282"},{"key":"2026042704500632000_2026.04.22.26351494v1.36","doi-asserted-by":"publisher","DOI":"10.2196\/56892"},{"key":"2026042704500632000_2026.04.22.26351494v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.08.2223"},{"key":"2026042704500632000_2026.04.22.26351494v1.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2010.11.013"},{"key":"2026042704500632000_2026.04.22.26351494v1.39","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2018.0198"},{"key":"2026042704500632000_2026.04.22.26351494v1.40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262926"},{"key":"2026042704500632000_2026.04.22.26351494v1.41","unstructured":"Orme B. CBC Questionnaires and Designs. Sawtooth Software. https:\/\/sawtoothsoftware.com\/help\/lighthouse-studio\/manual\/cbc-questionnaires-designs.html"},{"key":"2026042704500632000_2026.04.22.26351494v1.42","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-017-0635-3"},{"key":"2026042704500632000_2026.04.22.26351494v1.43","unstructured":"Orme BK . Getting Started with Conjoint Analysis. Research Publishers, LLC; 2014:234."},{"key":"2026042704500632000_2026.04.22.26351494v1.44","doi-asserted-by":"publisher","DOI":"10.1097\/01.NNR.0000319499.52122.d2"},{"key":"2026042704500632000_2026.04.22.26351494v1.45","unstructured":"Orme BK , Chrzan K. Becoming an Expert in Conjoint Analysis. Sawtooth Software, Inc; 2017:327."},{"key":"2026042704500632000_2026.04.22.26351494v1.46","unstructured":"Sawtooth Software I. Testing the CBC Design. Sawtooth Software, Inc. Updated 2\/6\/2023. 2025. https:\/\/sawtoothsoftware.com\/help\/lighthouse-studio\/manual\/cbc-test-design.html"},{"key":"2026042704500632000_2026.04.22.26351494v1.47","unstructured":"Latent Class Technical Paper (2021)."},{"key":"2026042704500632000_2026.04.22.26351494v1.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.04.004"},{"key":"2026042704500632000_2026.04.22.26351494v1.49","unstructured":"Vannette D. Survey Straightlining: What is it? How can it hurt you? And how to protect against it. 2018. https:\/\/www.qualtrics.com\/blog\/straightlining-what-is-it-how-can-it-hurt-you-and-how-to-protect-against-it\/"},{"key":"2026042704500632000_2026.04.22.26351494v1.50","unstructured":"Orme B. Consistency Cutoffs to Identify \u201cBad\u201d Respondents in CBC, ACBC, and MaxDiff."},{"key":"2026042704500632000_2026.04.22.26351494v1.51","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10546-w"},{"key":"2026042704500632000_2026.04.22.26351494v1.52","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26099"},{"key":"2026042704500632000_2026.04.22.26351494v1.53","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2023.2240067"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.04.22.26351494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:50:35Z","timestamp":1777290635000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.04.22.26351494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":53,"URL":"https:\/\/doi.org\/10.64898\/2026.04.22.26351494","relation":{},"subject":[],"published":{"date-parts":[[2026,4,23]]},"subtype":"preprint"}}